86 search results for Lung
Asia
and published evidence-based, regionally specific, clinical practice guidelines for the treatment of lung
https://www.nccn.org/global/global-program/asiaNCCN_ExhibitHall_Floorplan_2024
Crossroads4Hope ............................... A9 Global Colon Cancer Association ...... A1 GO2 for Lung
https://www.nccn.org/docs/default-source/education-research/nccn_exhibithall_floorplan_2024.pdf?sfvrsn=66d8d76f_4NCCN SOSF 2024 Thirteenth Annual Summary
, NCCN Panelists included: • Arun Krishna, PhD, Vice-President, US Franchise Head & Lung Cancer, featured on the panel. Dr. Krishna discussed the importance of lung cancer screening because the U.S., challenges and focuses on education and processes to improve screening uptake. Mobile lung and mammography
https://www.nccn.org/docs/default-source/oncology-policy-program/nccn-sosf-2024-thirteenth-annual-summary.pdf?sfvrsn=5346b0f5_1Submission Request Form
- 3.2025 Lung Cancer Screening - 1.2025 Management of Immunotherapy-Related Toxicities - 1.2025, - 4.2024 Non-Small Cell Lung Cancer - 3.2025 Occult Primary - 2.2025 Older Adult Oncology - 1.2025, Detection - 2.2024 Rectal Cancer - 5.2024 Small Bowel Adenocarcinoma - 2.2025 Small Cell Lung
https://www.nccn.org/guidelines/submissions-request-to-the-guidelines-panels/submission-request-form30 Years of NCCN
care and outcomes. The first disease types available were: Acute Leukemia and Breast, Colon, Lung
https://www.nccn.org/home/about/nccn-history/30-years-of-nccnTreatment by Cancer Type
Version: 1.2025 Non-Small Cell Lung Cancer, Small Cell Lung Cancer Version: 4.2025
https://www.nccn.org/guidelines/category_1Download a printable flyer about Clinical Trials to share with others!
Patient Advocate SVP Patient Services and Health Care Delivery LUNGevity F i n d i n g
https://www.nccn.org/docs/default-source/patient-resources/webinar-flyer/download-a-printable-flyer-about-clinical-trials-to-share-with-others!.pdf?sfvrsn=3736bfe0_1News
Treatment for Stage 1 Non-Small Cell Lung Cancer in High-Risk Patients (Case Comprehensive Cancer Center
https://www.nccn.org/home/newsMember Institution Toolkit
for Patients Free Patient Webinar: Small Cell Lung Cancer Not a CE-certified activity, Lung Cancer Earn CE credit. EVENT DETAILS May 31-June 2, 2025
https://www.nccn.org/members/member-institution-portal/member-institution-toolkitYoung Investigator Awards
Mapping to Improve Lung Cancer Screening Among Black Veterans Ravi Parikh, MD, MPP
https://www.nccn.org/education-research/nccn-oncology-research-program/young-investigator-awardsYoung Investigator Awards
Neelima Navuluri, MD, MPH, Duke Cancer Institute Intervention Mapping to Improve Lung Cancer Screening
https://www.nccn.org/patientresources/patient-resources/nccn-foundation/young-investigator-awardsCalendar of Events
April 21, 2025 Live Webinar for Patients Free Patient Webinar: Small Cell Lung Cancer
https://www.nccn.org/education-research/educational-events-and-programs/calendar-of-eventsNCCN Guidance on Inclusive Language
(eg, a person with lung cancer rather than a lung cancer patient ). An illness or disease, , 2022. IASLC Language Guide. International Association for the Study of Lung Cancer; 2021. Available
https://www.nccn.org/docs/default-source/about/nccn-guidance-on-inclusive-language.pdf?sfvrsn=53c8c78f_1Ways to Give
interested in giving toward specific areas of cancer (i.e. breast cancer, lung cancer, etc.) should
https://www.nccn.org/patientresources/patient-resources/nccn-foundation/ways-to-giveGuidelines With Evidence Blocks
Version 2.2024 Non-Small Cell Lung Cancer Version 11.2024 Occult Primary, Adenocarcinoma Version 1.2025 Small Cell Lung Cancer Version 3.2025 Soft Tissue Sarcoma
https://www.nccn.org/guidelines/guidelines-with-evidence-blocksFramework for Resource Stratification
3.2025 Non-Small Cell Lung Cancer Basic Resources Version 4.2024 Core
https://www.nccn.org/global/what-we-do/nccn-framework-for-resource-stratification-of-nccn-guidelinesAC2024 Exhibit Guide
Association ............ A1 GO2 for Lung Cancer .............................. A16 Head and Neck, , and thoracic cancers, which includes lung cancer. Driven by science, we are committed
https://www.nccn.org/docs/default-source/education-research/ac2024-exhbit-guide.pdf?sfvrsn=a658efb9_11The Impact of Policy Regulation on Guideline-Concordant Care Globally Summary Article
based on the WHO EML for cancers with the highest incidence in LLMICs. These cancers include lung
https://www.nccn.org/docs/default-source/global/the-impact-of-policy-regulation-on-guideline-concordant-care-globally-summary-article.pdf?sfvrsn=b36df21a_3Chemotherapy Order Templates Reviewer Acknowledgement
Fox Chase Cancer Center Non-Small Cell Lung Cancer Sally, of Pennsylvania Small Cell Lung Cancer Sally Barbour, PharmD
https://www.nccn.org/compendia-templates/nccn-templates-main/nccn-chemotherapy-order-reviewer-engagement2021_Elevating_Cancer_Equity_Webinar_Slides
Prostate Cancer Lung Cancer 13 © National Comprehensive Cancer Network, Inc. 2021, All Rights, Prevalence Va r i e s G e o g raphically 2017 Medicare Population 25 Lung Cancer Prostate Cancer
https://www.nccn.org/docs/default-source/oncology-policy-program/2021_elevating_cancer_equity_webinar_slides.pdf?sfvrsn=e11f66e4_4